{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:36:59Z","timestamp":1790221019212,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":1888,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AR062705"],"award-info":[{"award-number":["AR062705"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AR063289"],"award-info":[{"award-number":["AR063289"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jbc.org"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1074\/jbc.m115.663963","type":"journal-article","created":{"date-parts":[[2015,5,16]],"date-time":"2015-05-16T00:53:46Z","timestamp":1431737626000},"page":"16918-16928","update-policy":"https:\/\/doi.org\/10.1074\/jbc.f110.005975","source":"Crossref","is-referenced-by-count":23,"title":["The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway"],"prefix":"10.1016","volume":"290","author":[{"given":"Yanmei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry C.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving M.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.663963_bib1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coph.2005.07.004","article-title":"Parathyroid hormone: a bone anabolic and catabolic agent","volume":"5","author":"Poole","year":"2005","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1074\/jbc.M115.663963_bib2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr. Rev"},{"key":"10.1074\/jbc.M115.663963_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cellsig.2009.02.012","article-title":"PTH and PTHrP signaling in osteoblasts","volume":"21","author":"Datta","year":"2009","journal-title":"Cell Signal"},{"key":"10.1074\/jbc.M115.663963_bib4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"New Engl. J. Med"},{"key":"10.1074\/jbc.M115.663963_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/0253-7613.93869","article-title":"Severe hypercalcemia due to teriparatide","volume":"44","author":"Karatoprak","year":"2012","journal-title":"Indian J. Pharmacol"},{"key":"10.1074\/jbc.M115.663963_bib6","doi-asserted-by":"crossref","first-page":"e74191","DOI":"10.1371\/journal.pone.0074191","article-title":"Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma","volume":"8","author":"Hu","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M115.663963_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2005.05.098","article-title":"Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function","volume":"333","author":"Zavrski","year":"2005","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M115.663963_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21310","article-title":"The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo","volume":"84","author":"Pennisi","year":"2009","journal-title":"Am. J. Hematol"},{"key":"10.1074\/jbc.M115.663963_bib9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/leu.2014.27","article-title":"Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy","volume":"28","author":"Berenson","year":"2014","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M115.663963_bib10","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/sj.leu.2404806","article-title":"Bortezomib inhibits human osteoclastogenesis","volume":"21","author":"von Metzler","year":"2007","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M115.663963_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/leu.2012.183","article-title":"The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects","volume":"27","author":"Hurchla","year":"2013","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M115.663963_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1083\/jcb.201403138","article-title":"HDAC4 integrates PTH and sympathetic signaling in osteoblasts","volume":"205","author":"Obri","year":"2014","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M115.663963_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bone.2012.10.001","article-title":"NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts","volume":"52","author":"Wang","year":"2013","journal-title":"Bone"},{"key":"10.1074\/jbc.M115.663963_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-59745-401-8_18","article-title":"Generation of osteoclasts in vitro, and assay of osteoclast activity","volume":"135","author":"Takahashi","year":"2007","journal-title":"Methods Mol. Med"},{"key":"10.1074\/jbc.M115.663963_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/bonekey.2014.65","article-title":"Generation and culture of osteoclasts","volume":"3","author":"Marino","year":"2014","journal-title":"Bonekey Rep"},{"key":"10.1074\/jbc.M115.663963_bib16","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.leukres.2008.02.019","article-title":"Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions","volume":"32","author":"Boissy","year":"2008","journal-title":"Leuk. Res"},{"key":"10.1074\/jbc.M115.663963_bib17","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/leu.2014.69","article-title":"A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity","volume":"28","author":"Eda","year":"2014","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M115.663963_bib18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jcb.22454","article-title":"Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells","volume":"109","author":"Shinoda","year":"2010","journal-title":"J. Cell Biochem"},{"key":"10.1074\/jbc.M115.663963_bib19","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.20459","article-title":"Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription","volume":"50","author":"Wang","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1074\/jbc.M115.663963_bib20","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1038\/sj.onc.1210191","article-title":"The ubiquitin-proteasome system regulates p53-mediated transcription at p21waf1 promoter","volume":"26","author":"Zhu","year":"2007","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M115.663963_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2141.2009.08009.x","article-title":"Characterization of Wnt\/\u03b2-catenin signalling in osteoclasts in multiple myeloma","volume":"148","author":"Qiang","year":"2010","journal-title":"Br. J. Haematol"},{"key":"10.1074\/jbc.M115.663963_bib22","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1073\/pnas.0609303104","article-title":"Phosphorylation of tau antagonizes apoptosis by stabilizing \u03b2-catenin, a mechanism involved in Alzheimer's neurodegeneration","volume":"104","author":"Li","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.663963_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1074\/jbc.M115.663963_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med"},{"key":"10.1074\/jbc.M115.663963_bib25","doi-asserted-by":"crossref","first-page":"48868","DOI":"10.1074\/jbc.M208494200","article-title":"Parathyroid hormone stimulates receptor activator of NF\u03baB ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein","volume":"277","author":"Fu","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.663963_bib26","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/MCB.00356-06","article-title":"Parathyroid hormone controls receptor activator of NF-\u03baB ligand gene expression via a distant transcriptional enhancer","volume":"26","author":"Fu","year":"2006","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.M115.663963_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/JBMR.0301226","article-title":"PTH differentially regulates expression of RANKL and OPG","volume":"19","author":"Huang","year":"2004","journal-title":"J. Bone Miner. Res"},{"key":"10.1074\/jbc.M115.663963_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jcp.21787","article-title":"Proteasome inhibitors impair RANKL-induced NF-\u03baB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and I\u03baB\u03b1 signaling cascades","volume":"220","author":"Ang","year":"2009","journal-title":"J. Cell. Physiol"},{"key":"10.1074\/jbc.M115.663963_bib29","doi-asserted-by":"crossref","first-page":"50259","DOI":"10.1074\/jbc.M307444200","article-title":"Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism","volume":"278","author":"Bellido","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.663963_bib30","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"\u03b2-Catenin is a target for the ubiquitin-proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J"},{"key":"10.1074\/jbc.M115.663963_bib31","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/jbmr.28","article-title":"Smurf1 inhibits mesenchymal stem cell proliferation and differentiation into osteoblasts through JunB degradation","volume":"25","author":"Zhao","year":"2010","journal-title":"J. Bone Miner. Res"},{"key":"10.1074\/jbc.M115.663963_bib32","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jcb.20891","article-title":"Modulation of mouse RANKL gene expression by Runx2 and PKA pathway","volume":"98","author":"Mori","year":"2006","journal-title":"J. Cell Biochem"},{"key":"10.1074\/jbc.M115.663963_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","article-title":"Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts","volume":"89","author":"Komori","year":"1997","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.663963_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S8756-3282(01)00692-5","article-title":"Cbfa1 does not regulate RANKL gene activity in stromal\/osteoblastic cells","volume":"30","author":"O'Brien","year":"2002","journal-title":"Bone"},{"key":"10.1074\/jbc.M115.663963_bib35","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jcb.20506","article-title":"Effects of parathyroid hormone on Wnt signaling pathway in bone","volume":"95","author":"Kulkarni","year":"2005","journal-title":"J. Cell Biochem"},{"key":"10.1074\/jbc.M115.663963_bib36","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1074\/jbc.M110.102970","article-title":"Parathyroid hormone receptor directly interacts with dishevelled to regulate \u03b2-catenin signaling and osteoclastogenesis","volume":"285","author":"Romero","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.663963_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1196\/annals.1402.029","article-title":"Balanced regulation of proliferation, growth, differentiation, and degradation in skeletal cells","volume":"1116","author":"Blair","year":"2007","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1074\/jbc.M115.663963_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cell.2005.01.035","article-title":"Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation","volume":"121","author":"Yamashita","year":"2005","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.663963_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1083\/jcb.201105063","article-title":"Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4","volume":"195","author":"Backs","year":"2011","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.M115.663963_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1091\/mbc.e10-07-0616","article-title":"Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility","volume":"22","author":"Cernotta","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.M115.663963_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820402467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820402467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.663963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T01:05:36Z","timestamp":1717895136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820402467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":41,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0021925820402467"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.663963","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}